Peptide research has moved well beyond a niche area of pharmaceutical science. Hundreds of peptide candidates are being evaluated clinically, established peptide drugs continue to influence drug development, and regulators are paying closer attention to peptide characterization, manufacturing, impurities, higher-order structure, and generic development. The latest data also shows why 2026 is an important year[ Read more…]

